This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
CNO Financial (CNO) Hits 52 Week High: Will the Rally Remain?
by Zacks Equity Research
CNO Financial's (CNO) shares rally as investors get optimistic about its strategic initiatives and cost-curbing measures.
CNO Financial's (CNO) Q4 Earnings Miss Estimates, Rise Y/Y
by Zacks Equity Research
CNO Financial's (CNO) fourth-quarter earnings gain from better revenues as well as decreased expenses, partly offset by lower new annualized premiums.
CNO Financial (CNO) Lags Q4 Earnings Estimates
by Zacks Equity Research
CNO (CNO) delivered earnings and revenue surprises of -1.72% and 26.72%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Are Investors Undervaluing CNO Financial (CNO) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CNO Financial (CNO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
CNO (CNO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Assurant (AIZ), LEVC Tie Up for Enhanced EV Warranty Plan
by Zacks Equity Research
Assurant (AIZ) partners with LEVC for devising a EV warranty plan, which will boost Assurant's presence in the automotive service contract space.
Is CNO Financial (CNO) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Should You Add MGIC Investment (MTG) to Your Portfolio?
by Zacks Equity Research
MGIC Investment (MTG) is poised to grow given its strong persistency, higher average investment portfolio balance and financial flexibility.
CNO Financial (CNO) Up 48% in 6 Months: More Room to Run?
by Zacks Equity Research
CNO Financial (CNO) is set to grow on diversified product portfolio, integrated care platform and solid cash flows.
CNO (CNO) Up 11.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
CNO (CNO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why You Should Retain CNO Financial (CNO) in Your Portfolio
by Zacks Equity Research
Riding on technology and cost-curbing measures, CNO Financial (CNO) holds potential to reap benefits for investors.
MGIC Investment (MTG) Looks Good: Stock Adds 5.3% in Session
by Zacks Equity Research
MGIC Investment (MTG) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Is CNO Financial (CNO) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
MetLife (MET) Earnings and Revenues Beat Estimates in Q3
by Zacks Equity Research
MetLife's (MET) third-quarter results reflect sound underwriting results and reduced costs, partly offset by muted revenues.
Radian Group (RDN) Q3 Earnings Beat Estimates, Tumble Y/Y
by Zacks Equity Research
Radian Group's (RDN) third-quarter results reflect strong housing market leading to higher mortgage insurance business written, partly offset by higher loss provision.
CNO Financial's (CNO) Q3 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
CNO Financial's (CNO) third-quarter 2020 results reflect improving revenues and reduced expenses, partly offset by decline in annuity collected premiums.
CNO Financial (CNO) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
CNO (CNO) delivered earnings and revenue surprises of 71.74% and 17.97%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
6 Multiline Insurers to Watch Out for Amid Operational Challenges
by Tanuka De
Better pricing, product redesigns and increased adoption of technology are expected to aid multiline insurers like CI, MET, CNO, HMN, ORI, and MTG. However, a low-rate environment remains a headwind.
Insurance Stock Q3 Earnings Roster for Nov 2: AIZ, CNA & More
by Tanuka De
Third-quarter results AIZ, CNA, KMPR, CNO and HMN are likely to reflect improved pricing, strong retention, and new business, partially offset by cat losses and lower interest rate.
Why Earnings Season Could Be Great for CNO Financial (CNO)
by Zacks Equity Research
CNO Financial (CNO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in the Cards for Assurant (AIZ) This Earnings Season?
by Zacks Equity Research
Assurant's (AIZ) Q3 results are likely to reflect higher claims activity in Connected Living, mobile seasonality and lower mortality risk.
Prudential (PRU) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Prudential's (PRU) Q3 results are likely to reflect the re-pricing of products and shift toward lower risk and less capital-intensive products.
What's in Store for Hartford Financial (HIG) Q3 Results?
by Zacks Equity Research
Hartford Financial's (HIG) Q3 results to reflect muted revenues and weak performances at both its Personal Lines and Commercial businesses.
CNO Financial (CNO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
CNO (CNO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Everest Re Group (RE) to Report Q3: What's in the Cards?
by Zacks Equity Research
Everest Re (RE) Q3 earnings are likely to have benefited from strong renewal retention and better pricing though cat loss to weigh on underwriting profit.